Study of Online Antidepressant Forums Reveals Long Lasting Withdrawal Effects
Effects of discontinuing SSRIs and SNRIs reported on an online forum indicate significant and long-lasting withdrawal symptoms.
Interview: Researcher Runs Trial on Antidepressant Withdrawal
Tony Kendrick, a professor of Primary Care at the University of Southampton, has found through his research and practice that too many people are being prescribed antidepressants long-term without the information and support necessary to get off of them.
Antidepressant Withdrawal Misdiagnosed as Functional Disorder
Adverse physiological symptoms of antidepressant withdrawal are regularly mistaken to be other problems to the detriment of the patient.
Mental Health Staff Reluctant to Support Service Users in Tapering Antipsychotics, Study Finds
Study reveals schizophrenia patients find little support from mental health staff in reducing side effects-heavy drugs.
Review Documents Severe Withdrawal Effects of Psychiatric Drugs
Researchers find that most psychiatric drugs cause severe withdrawal despite attempt s to gradually decrease the dosage.
Researchers Document Protracted Withdrawal from Antidepressants
Protracted Withdrawal Syndrome characterized by long-term adverse experiences after coming off of antidepressants.
Internet Forum for Tapering Psychiatric Drugs Provides Novel Insights
After 15 years, the founder of SurvivingAntidepressants.org, Adele Framer, shares what she has learned about the science of withdrawing from psychiatric drugs.
Study Highlights Difficulty of Antipsychotic Withdrawal
New research finds insomnia, anxiety, and depression are common symptoms of antipsychotic withdrawal, highlighting difficulties of discontinuation.
Tapering Strips Help People Discontinue Antidepressants
A new study by Peter Groot and Jim van Os has found that tapering strips help people successfully discontinue antidepressant medications.
Psychological Interventions Can Help When Tapering Off Antidepressants
Meta-analysis of antidepressant tapering finds CBT and MBCT can aid in tapering, but limited studies met inclusion criteria.
Systematic Review Finds Antidepressant Withdrawal Common and Potentially Long-lasting
Prominent researchers conduct a review of antidepressant withdrawal incidence, duration, and severity. Results lead to call for new clinical guidelines.
Antipsychotic Drugs and Relapse
Researchers from Germany, Greece and the U.S. reviewed the literature on relapse at 7 to 12 months following initiation of antipsychotic treatment. They conclude...
Biological Explanations for Antidepressant Withdrawal
Two South African researchers review scientific understanding of the brain changes that lead to antidepressant discontinuation syndrome (ADS) in Human Psycho-pharmacology: Clinical and Experimental....
Study Examines the Difficulty of Withdrawing from Antidepressant Drugs
Correcting unnecessary long-term antidepressant use is difficult and met with apprehension by providers and service-users.
Differentiation of SSRI and Benzo Dependence/Withdrawal “Not Rational”
Researchers from the Cochrane Center and University of Copenhagen in Denmark, publishing in the May issue of Addiction, "explore the rationale for claiming that...
Fear and Belief in “Chemical Imbalance” Prevent People from Coming Off Antidepressants
Researchers interviewed people who were given medical advice to discontinue antidepressants.
Researchers: Antidepressant Withdrawal, Not “Discontinuation Syndrome”
Researchers suggest that the pharmaceutical industry had a vested interest in using the term “discontinuation” in order to hide the severity of physical dependence and withdrawal reactions many people experience from antidepressants.
Psychiatry’s Top Experts Acknowledge Lasting Harms of Antidepressant Withdrawal
Royal College of Psychiatrists’ former president demands support for patients coming off antidepressants.
New Clinical Guidelines on Deprescribing Benzodiazepines
New guidelines recommend deprescribing benzodiazepine receptor agonists for adults.
Neuropsychological Tests Reveal Consequences of Polypharmacy
Neuropsychological assessments reveal the cognitive, occupational, and social impact of polypharmacy in psychiatry.
Study Shows Success With Reduced Antipsychotic Use
People who reduced antipsychotic use by tapering were doing just as well after five years as those who continued using the drugs.
New Research on Patient-Centered Deprescribing for Antipsychotics
Researchers review the risks and benefits of deprescribing from antipsychotic drugs and advocate for a patient-centered approach to tapering.
Prescribers Often Fail to Support Patients Discontinuing Antidepressants, Study Finds
Study reveals most patients are dissatisfied with prescribers' support when discontinuing antidepressants.
New Study Examines User Experience of Discontinuing Psychiatric Medications
Researchers find that support and self-care were helpful for users during discontinuation, but that mental health professionals were not very helpful.
New Study Asks Doctors About Barriers to Deprescribing
Researchers interviewed doctors about the barriers that prevent them from being able to decrease excess medications.
